Report Takes Look At Circumstances Surrounding Doctor-NP Accused of Overprescribing
the Clinical Pain Advisor take:
An opinion piece recently recently published in The Wall Street Journal examines the circumstances surrounding a physician and a nurse-practitioner who were recently acquitted on overprescription charges.
The piece notes that although federal drug-enforcement guidelines make overprescribing a felony, the line about what defines "unreasonable" prescriptions remains "far from clear."
The piece frames the discussion by discussing the case of Boston-area pain physician Joseph Zolot and nurse-practitioner Lisa Pliner, who were indicted in 2011 with respect to patients they treated five years previously.The pair pleaded not guilty and the jury acquitted them, agreeing with their argument that the clinicians were not responsible for their patient's later abuses of their prescription painkillers.
Nine years ago, according to the report, the DEA did, for a short two months, release guidelines for the administration of narcotic analgesics and then took it down, thus essentially leaving doctors and law enforcement in the dark of what is and is not an over-prescription.
The opinion piece notes that the "the DEA’s retraction coincided with the federal prosecution of Virginia pain physician Dr. William Hurwitz, who was eventually convicted. The timing struck many observers as suspicious—did prosecutors realize that Dr. Hurwitz’s lawyers could claim that his prescribing practices conformed to its guidelines?"
The piece goes on to suggest that the agency has issued not issued any further guidance since that time.
In the comments section following the piece, several people - many of whom had identified as being in chronic pain - suggested that the issue of fear of prescribing pain medications has actually led to undertreatment of their chronic pain.
Hydrocodone painkillers face increased federal restriction
Clinical Pain Advisor Articles
- Chronic Neuropathic Pain Updated Classification by IASP for ICD-11
- Buprenorphine-Naloxone Found to Be More Cost-Effective Than Extended-Release Naltrexone
- Ultrasound-Guided C2 Coblation May Be Effective for Cervicogenic Headache
- Meta-Analysis of Opioid Treatment for Chronic Noncancer Pain
- Opioids Found to Increase Risk for Community-Acquired Pneumonia, Particularly in HIV
- Reviewing the Use of Buprenorphine in Perioperative Pain Management
- Early Physical Therapy for Musculoskeletal Pain May Reduce Opioid Use
- External Trigeminal Nerve Stimulation May Alleviate Migraine Pain
- IASP Updates Diagnosis Criteria for Chronic Primary Pain for ICD-11
- Galcanezumab Provides Persistent Preventive Effects in Episodic, Chronic Migraine
- Comparable Analgesia With Low-Dose IV Ketamine, Morphine for Acute Pain
- Benzodiazepines, if Prescribed, May Not Affect Methadone Treatment Retention
- When Opioid Prescribing Guidelines Become Rules
- IV Fluid Confers No Significant Treatment Effect on Migraine Pain
- American Headache Society Releases Position Statement on Novel Preventive and Acute Migraine Treatments